PETS · Petmed Express Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.66M | $44.36M | $51.18M | $78.24M | $65.32M | $71.00M | - | - | - | - |
| Cost of Revenue | - | $31.95M | $36.78M | $49.98M | $38.08M | $42.26M | $55.72M | $47.43M | $50.94M | $50.24M |
| Gross Profit | $9.46M | $12.41M | $14.40M | $17.97M | $14.91M | $17.31M | $22.53M | $17.88M | $20.06M | $19.94M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $12.19M | $14.18M | $12.95M | $4.87M | $10.79M | $10.49M | $15.71M | $13.43M | $13.28M | $9.35M |
| Total Operating Expenses | $19.93M | $20.80M | $48.53M | $13.59M | $15.36M | $16.76M | $24.65M | $20.96M | $20.50M | $16.45M |
| D&A | $2.40M | $2.28M | $2.28M | $1.72M | $1.59M | $1.66M | $753.0K | $941.0K | $858.0K | $753.0K |
| Operating Income | ($10.47M) | ($8.38M) | ($34.13M) | $4.39M | ($450.0K) | $554.0K | ($2.13M) | ($3.07M) | ($441.0K) | $3.49M |
| Interest Expense | $400.0K | - | - | - | - | - | - | - | - | - |
| Income Tax | $11.0K | $9.0K | $9.0K | $958.0K | $465.0K | ($1.40M) | ($115.0K) | ($618.0K) | $453.0K | $1.03M |
| Net Income | ($10.55M) | ($8.52M) | ($34.15M) | $3.75M | ($707.0K) | $2.33M | ($887.0K) | ($2.03M) | ($70.0K) | $2.77M |
| EPS - Basic | ($0.50) | ($0.41) | ($1.65) | $0.18 | ($0.03) | $0.11 | ($0.04) | ($0.10) | $0.00 | $0.14 |
| EPS - Diluted | ($0.50) | ($0.41) | ($1.65) | $0.18 | ($0.03) | $0.11 | ($0.04) | ($0.10) | $0.00 | $0.14 |
Balance Sheet
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26.91M | $36.10M | $41.13M | $54.72M | $50.10M | $52.05M | $55.30M | $49.44M | $53.47M | $104.09M |
| Accounts Receivable | $1.56M | $1.97M | $1.60M | $2.32M | $2.26M | $1.62M | $3.28M | $1.93M | $2.17M | $1.74M |
| Inventory | $12.21M | $14.77M | $18.36M | $16.20M | $11.79M | $28.56M | - | - | - | - |
| Accounts Payable | $20.30M | $19.12M | $20.04M | $23.56M | $10.95M | $16.95M | $37.02M | $38.85M | $25.38M | $25.21M |
| Current Assets | $48.51M | $59.45M | $67.89M | $78.87M | $68.38M | $70.78M | $93.65M | $95.55M | $85.66M | $131.45M |
| Total Assets | $87.97M | $100.30M | $109.84M | $148.70M | $144.79M | $146.03M | $169.88M | $173.35M | $159.27M | $164.12M |
| Current Liabilities | $54.77M | $56.68M | $57.62M | $62.77M | $47.96M | $48.83M | $72.16M | $72.40M | $40.70M | $36.50M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $55.20M | $57.24M | $58.29M | $63.57M | $48.61M | $49.60M | $73.15M | $73.29M | $45.60M | $40.32M |
| Stockholders' Equity | $32.77M | $43.06M | $51.55M | $85.13M | $96.18M | $96.43M | $96.73M | $100.06M | $113.67M | $123.80M |
| Retained Earnings | $13.32M | $23.87M | $32.39M | $66.54M | $78.19M | $78.89M | $71.56M | $76.56M | $91.88M | $105.49M |
Cash Flow
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($12.27M) | ($8.52M) | - | - | $562.0K | - | - | $6.38M |
| Investing Cash Flow | - | - | ($1.29M) | ($683.0K) | - | - | ($37.01M) | - | - | ($5.98M) |
| Financing Cash Flow | - | - | ($30.0K) | ($104.0K) | - | - | ($6.10M) | - | - | ($6.06M) |
| CapEx | - | - | $1.29M | $683.0K | - | - | $1.15M | - | - | $982.0K |
| Free Cash Flow | - | - | ($13.56M) | ($9.20M) | - | - | ($591.0K) | - | - | $5.40M |
Ratios
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q1 '25 | Q3 '25 | Q2 '25 | Q1 '24 | Q3 '24 | Q2 '24 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 23.3% | 28.0% | 28.1% | 23.0% | 22.8% | 24.4% | - | - | - | - |
| Operating margin | -25.7% | -18.9% | -66.7% | 5.6% | -0.7% | 0.8% | - | - | - | - |
| EBITDA margin | -19.8% | -13.8% | -62.2% | 7.8% | 1.7% | 3.1% | - | - | - | - |
| Net margin | -26.0% | -19.2% | -66.7% | 4.8% | -1.1% | 3.3% | - | - | - | - |
| Free cash flow margin | - | - | -26.5% | -11.8% | - | - | - | - | - | - |
| FCF / Net income | - | - | 0.40 | -2.45 | - | - | 0.67 | - | - | 1.95 |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 30.0% | 32.0% | 25.3% | 6.2% | 16.5% | 14.8% | - | - | - | - |
| Effective tax rate | - | - | - | 20.3% | - | -151.5% | - | - | 118.3% | 27.1% |
| Return on assets | -12.0% | -8.5% | -31.1% | 2.5% | -0.5% | 1.6% | -0.5% | -1.2% | -0.0% | 1.7% |
| Return on equity | -32.2% | -19.8% | -66.3% | 4.4% | -0.7% | 2.4% | -0.9% | -2.0% | -0.1% | 2.2% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.89 | 1.05 | 1.18 | 1.26 | 1.43 | 1.45 | 1.30 | 1.32 | 2.10 | 3.60 |
| Quick ratio | 0.66 | 0.79 | 0.86 | 1.00 | 1.18 | 0.86 | 1.30 | 1.32 | 2.10 | 3.60 |
| Cash ratio | 0.49 | 0.64 | 0.71 | 0.87 | 1.04 | 1.07 | 0.77 | 0.68 | 1.31 | 2.85 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -26.2x | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 2.68 | 2.33 | 2.13 | 1.75 | 1.51 | 1.51 | 1.76 | 1.73 | 1.40 | 1.33 |
| Liabilities / Assets | 0.63 | 0.57 | 0.53 | 0.43 | 0.34 | 0.34 | 0.43 | 0.42 | 0.29 | 0.25 |
| Efficiency | ||||||||||
| Asset turnover | 0.46 | 0.44 | 0.47 | 0.53 | 0.45 | 0.49 | - | - | - | - |
| Inventory turnover | - | 2.16 | 2.00 | 3.08 | 3.23 | 1.48 | - | - | - | - |
| Days sales outstanding | 14d | 16d | 11d | 11d | 13d | 8d | - | - | - | - |
| Days inventory outstanding | - | 169d | 182d | 118d | 113d | 247d | - | - | - | - |
| Days payable outstanding | - | 218d | 199d | 172d | 105d | 146d | 243d | 299d | 182d | 183d |
| Cash conversion cycle | - | -34d | -5d | -43d | 21d | 109d | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | 23.3x | - | 33.5x | - | - | - | 116.0x |
| P / B | 2.1x | 1.2x | 1.3x | 1.0x | 1.0x | 0.8x | 1.0x | 1.5x | 1.8x | 2.7x |
| P / S | 1.7x | 1.2x | 1.3x | 1.1x | 1.5x | 1.1x | - | - | - | - |
| EV / EBITDA | - | - | - | 5.4x | 43.4x | 11.3x | - | - | 372.8x | 53.1x |
| Growth | ||||||||||
| Revenue growth (YoY) | -37.7% | -37.5% | -34.6% | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | -36.6% | -28.3% | -19.9% | -20.2% | -16.6% | -13.7% | 13.0% | 17.4% | 8.7% | -8.4% |
| Operating income growth (YoY) | -2226.4% | - | - | - | 85.4% | - | - | -299.7% | - | -35.6% |
| Net income growth (YoY) | -1392.6% | - | - | - | 65.1% | - | - | -10568.4% | - | -37.3% |
| EPS growth (YoY) | -1566.7% | - | - | - | 70.0% | - | - | - | - | -36.4% |
| EPS CAGR (3y) | - | - | - | -6.5% | - | -29.2% | - | - | - | -18.6% |
| EPS CAGR (5y) | - | - | - | -7.1% | - | -19.7% | - | - | - | -20.8% |
| FCF growth (YoY) | - | - | -47.4% | -1456.7% | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | -17.2% |
| Book value growth (YoY) | -65.9% | -55.3% | -39.5% | -12.0% | -3.9% | -15.2% | -21.9% | -25.1% | -17.7% | -12.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2026-03-31.
Business segments
$179.02M totalReportable Segment$179.02M · 100.0%
Product / service
$4.50M totalPartner Program$4.50M · 100.0%
Peer comparison
Same SIC group: Retail-Drug Stores and Proprietary Stores
Comparing PETMED EXPRESS INC against the 5 most active filers in the same SIC group.
Dividends
$0.00/share trailing 12 months
| Ex-date | Per share |
|---|---|
| Aug 11, 2023 | $0.3000 |
| Jun 5, 2023 | $0.3000 |
| Feb 16, 2023 | $0.3000 |
| Nov 17, 2022 | $0.3000 |
| Aug 11, 2022 | $0.3000 |
| May 19, 2022 | $0.3000 |
| Feb 4, 2022 | $0.3000 |
| Nov 5, 2021 | $0.3000 |
| Aug 5, 2021 | $0.3000 |
| May 13, 2021 | $0.3000 |
| Jan 29, 2021 | $0.2800 |
| Nov 6, 2020 | $0.2800 |
| Jul 30, 2020 | $0.2800 |
| May 14, 2020 | $0.2800 |
| Jan 31, 2020 | $0.2700 |
| Nov 1, 2019 | $0.2700 |
| Aug 1, 2019 | $0.2700 |
| May 16, 2019 | $0.2700 |
| Feb 1, 2019 | $0.2700 |
| Nov 2, 2018 | $0.2700 |
| Aug 2, 2018 | $0.2700 |
| May 17, 2018 | $0.2500 |
| Feb 2, 2018 | $0.2500 |
| Nov 3, 2017 | $0.2000 |